biOasis Receives Compelling Data From Texas Tech University On Its Herceptin(R) BT2111 Program - Yahoo! Finance
|
biOasis Technologies Inc. (TSX VENTURE:BTI) announced today that research underway at Texas Tech University Health Sciences Center (TTUHSC) has yielded some compelling data on preclinical studies designed to evaluate the pharmacokinetics of BT2111 (a proprietary conjugate of Transcend and Herceptin®) in animal models of breast cancer metastasis to the brain. Read the full story >> |
Related Stories
Celebrating Veterans: TTUHSC’s General Martin Clay’s Legacy of Service and Leadership
From his initial enlistment in the Army National Guard 36 years ago to his leadership in military and civilian health care management roles, Major General Martin Clay’s career has been shaped by adaptability, mission focus and service to others.
Texas Tech University Health Sciences Center School of Nursing Named Best Accelerated Bachelor of Science in Nursing Program in Texas
The TTUHSC School of Nursing Accelerated Bachelor of Science in Nursing (BSN) program has been ranked the No. 1 accelerated nursing program in Texas by RegisteredNursing.org.
TTUHSC Names New Regional Dean for the School of Nursing
Louise Rice, DNP, RN, has been named regional dean of the TTUHSC School of Nursing on the Amarillo campus.
Recent Stories
Lubbock ISD Middle School Students Become Docs for a Day
Lubbock Independent School District students from Atkins Middle School, McCool Academy and Evans Middle School became doctors for a day as the TTUHSC Student National Medical Association (SNMA) hosted Docs for a Day Nov. 10.
Celebrating Veterans: TTUHSC’s General Martin Clay’s Legacy of Service and Leadership
From his initial enlistment in the Army National Guard 36 years ago to his leadership in military and civilian health care management roles, Major General Martin Clay’s career has been shaped by adaptability, mission focus and service to others.
Project Team Analyzing Survey Results to Increase TTUHSC Grant Funding Capacity
A project team conducted a capacity-building study during the last year aimed at increasing TTUHSC's overall NIH funding. The team is led by Lance McMahon, Ph.D.